Search
for

    Glossary Mycophenolate Mofetil

    immunosuppressive drug used to prevent organ transplant rejection

    Mycophenolate Mofetil, often known as CellCept, is an immunosuppressive medication commonly used to prevent organ rejection in transplant patients. It works by inhibiting the proliferation of T and B lymphocytes, which are crucial components of the immune response, thereby reducing the likelihood of the body attacking the transplanted organ.

    Research 10 of 519

    1. Efficacy and safety of mycophenolate mofetil for lichen planopilaris Journal of The American Academy of Dermatology · 2010 · 66 citations
    2. Comparison of Systemic Mycophenolate Mofetil with Topical Clobetasol in Lichen Planopilaris: A Parallel-Group, Assessor- and Analyst-Blinded, Randomized Controlled Trial American journal of clinical dermatology · 2015 · 26 citations
    3. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis Clinical and Molecular Hepatology · 2016 · 12 citations
    4. Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication Journal of the South African Veterinary Association · 2010 · 11 citations
    5. [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis]. PubMed · 2012 · 2 citations
    6. Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study Asian Journal of Medical Sciences · 2025 · 1 citations
    7. BH09 Mycophenolate mofetil in the management of lichen planus pigmentosus in a woman with frontal fibrosing alopecia British Journal of Dermatology · 2024 · 1 citations
    8. Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice Annals of Medicine · 2025
    9. SIDE EFFECTS OF CYCLOSPORINE COMPARED TO TACROLIMUS AMONG YEMENI KIDNEY TRANSPLANT PATIENTS WHO SHARE THE SAME ADJUVANT AGENTS: MYCOPHENOLATE MOFETIL AND PREDNISONE Universal Journal of Pharmaceutical Research · 2020
    10. Efficacy and Safety of Treatment with Combine Mycophenolate Mofetil and Corticosteroid for Lupus Nephritis:A Multicenter Open-label Study Zhonghua linchuang mianyi he biantai fanying zazhi · 2008
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →